Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study

BACKGROUND: The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to ameliorate these effects on glucose and lipid met...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transplant Direct
Hoofdauteurs: Miura, Yoshifumi, Noguchi, Hiroshi, Okabe, Yasuhiro, Masutani, Kosuke, Tokunaga, Shoji, Nakamura, Masafumi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2019
Onderwerpen:
Kidney Transplantation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6415969/
https://ncbi.nlm.nih.gov/pubmed/30882027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000861
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items